TY - JOUR AB - Circular RNAs (circRNAs) are novel non‑coding RNAs that have been reported to be involved in the progression of numerous diseases. However, the clinical diagnostic value of circRNAs in female reproductive system diseases remains unknown. The present study is a systemic review and meta‑analysis of the available literature on circRNAs as novel biomarkers for female reproductive system diseases. Relevant studies were systematically searched using the PubMed, Embase, Web of Science and Cochrane Library databases. The data obtained from the included studies were analyzed by RevMan5.3 and STATA 14.2. A total of six studies involving 613 individuals across three types of disease examined the diagnostic capabilities of circRNAs. Within these publications, the pooled sensitivity of circRNAs was 0.70 (95% CI, 0.64‑0.76), and the pooled specificity was 0.70 (95% CI, 0.64‑0.75). The pooled positive likelihood ratio and negative likelihood ratio were 2.33 and 0.42, respectively. The diagnostic score was 1.70 and the pooled diagnostic odds ratio was 5.48. The area under the summary receiver operator characteristic curve was 0.76 (95% CI, 0.72‑0.79), indicating that circRNAs exhibited a moderate diagnostic value for female reproductive system diseases and may function as potential diagnostic biomarkers. However, further studies are required to verify the clinical applications of circRNAs. AD - Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui 241001, P.R. China AU - Ding,Jin AU - Lyu,Yuanyuan AU - Guo,Nan AU - Wang,Qingwei AU - Li,Lina AU - Ni,Guantai DA - 2020/04/01 DO - 10.3892/br.2020.1278 EP - 177 IS - 4 JO - Biomed Rep KW - circular RNA diagnostic biomarker meta‑analysis female reproductive system diseases PY - 2020 SN - 2049-9434 2049-9442 SP - 171 ST - Diagnostic value of circular RNAs in female reproductive system diseases: A PRISMA‑compliant meta‑analysis T2 - Biomedical Reports TI - Diagnostic value of circular RNAs in female reproductive system diseases: A PRISMA‑compliant meta‑analysis UR - https://doi.org/10.3892/br.2020.1278 VL - 12 ER -